1 min read
Rhythm Pharmaceuticals Shares Rise 5.4% by 12:22 p.m. ET
Viking Therapeutics was also part of speculation about two possible obesity-market targets.

Rhythm Pharmaceuticals shares were up 5.4% at 12:22 p.m. ET on Nov. 17 amid speculation that Eli Lilly was evaluating the drugmaker as a potential obesity-market acquisition target.
Viking Therapeutics was also part of the speculation, which involved two possible targets in the obesity market.